Cardiac amyloidosis in non-transplant cardiac surgery.
cardiovascular pathology
clinical review
coronary arterydisease
transplant
valve repair/replacement
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
revised:
14
04
2021
received:
05
12
2020
accepted:
15
04
2021
pubmed:
17
5
2021
medline:
14
7
2021
entrez:
16
5
2021
Statut:
ppublish
Résumé
Cardiac amyloidosis is a rare infiltrative cardiomyopathy that portends a poor prognosis. There is a growing recognition of co-existent aortic valve stenosis and transthyretin cardiac amyloidosis, with some studies suggesting that dual pathology may be associated increased risk of complication and mortality during surgical intervention. This review aims to evaluate the available literature on non-transplant cardiac surgical interventions in patients with cardiac amyloidosis, with particular focus on diagnosis, high surgical risk and areas of uncertainty that require further research.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2901-2910Subventions
Organisme : British Heart Foundation
ID : FS/19/35/34374
Pays : United Kingdom
Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Virchow R. Archiv fur pathologische anatomie and physiologie und fur klinischemedicin. Berlin. 1854;6:354-368.
Guvenc I. Localized amyloidosis of the head and neck. Amyloidosis. 2011:2150-3262.
Gilstrap L , Dominici F , Wang Y , et al. Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the united states. Circ Heart Fail. 2019;12(6):e005407.
Rubin J , Maurer M. Cardiac amyloidosis: overlooked, underappreciated and treatable. Annu Rev Med. 2020;71:201-219.
Tanskanen M , Perualinna T , Polvikoski T , et al. Senile systemic amyloidosis affects 25% of the very aged and associated with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232-239.
Gonzalez-Lopez E , Gallego-Delgado M , Guzzo-Merello , et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36(38):2585-2594.
Castano A , Narotsky DL , Hamid N , et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J. 2017;38:2879-2887.
Saraiva MR . Transthyretin mutations in health and disease. Hum Mutat. 1995;5(3):191-196.
Jacobson DR , Pastore RD , Yaghoubian R , et al. Variant-sequence transthyretin (isoleucine 122) in late onset cardiac amyloidosis in black Americans. N Engl J Med. 1997;336(7):466-473.
Mankad AK , Seray I , Shah KB . Light-chain cardiac amyloidosis. Curr Prob Cancer. 2017;41:144-156.
Maurer MS , Elliot P , Comenzo R , Semigran M , Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circ J. 2017;135(14):1357-1377.
Longhi S , Lorenzini M , Garliardi C , et al. Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis. JACC Cardiovas Imaging. 2016;9:325-327.
Dispenzieri A , Gertz MA , Kyle RA , et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2004;104:1881-1887.
Piper C , Butz T , Farr M , Faber L , Oldenburg O , Horstkotte D. How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy. Amyloid. 2010;17(1):1-9.
Mohty D , Damy T , Cosnay P , et al. Cardiac amyloidosis; updates in diagnosis and management. Arch Cardiovasc Dis. 2013;106(10):528-540.
Phelan D , Collier P , Thavendiranathan P , et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442-1448.
Treibel TA , Fontana M , Gilbertson JA , et al. Occult transthyretin cardiac amyloidosis in severe calcific aortic stenosis. Circ Cardiovasc Imaging. 2016;9(8):e005066.
Knight DS , Zumbo G , Barcella W , et al. Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles. JACC Cardiovasc Imaging. 2019;12(5):823-833.
Katzmann JA , Abraham RS , Dispenzieri A , Lust JA , Kyle RA . Diagnostic performance of quantitative {kappa} and {lambda} free light chain assays in clinical practice. Clin Chem. 2005;51:878-881.
Fontanta M , Pica S , Reant P , et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circ. 2015;132(16):1570-1579.
Karamitsos TD , Pichnik SK , Banypersad SM , et al. Non contrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):489-497.
Banypersad SM , Sado DM , Flett AS , et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. 2013;6(1):34-39.
Castano A , Haq M , Narotsky DL , et al. Multicenter study of planar technetrium 99m pyrophosphate cardiac imaging. JAMA cardiol. 2016;1(8):880-889.
Linke RP , Oos R , Wiegel NM . Improvements and practical guide for a more precise diagnosis of amyloid and the different amyloidoses. In: Uversky VN , Fink AL , eds. Protein Misfolding, Aggregation and Conformational Disease. Springer; 2006:239-276.
Linke RL , Oos R , Wiegel NM , Nathrath WBJ . Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem. 2006;108(3):197-208.
Maurer MS , Schwartz JH , Gundapaneni B , et al. Tafamidis treatment for patient with transthyretinin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007-1016.
Sousa M , Monohan G , Rajagopalan N , Grigorian A , Guglin M. Heart transplantation in cardiac amyloidosis. Heart Fail Rev. 2017;22:317-327.
Lindroos M , Kupari M , Heikkila J , Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225.
Cavalcante JL , Rijal S , Abdelkarim I , et al. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J Cardio Magnetic Resonance. 2017;19:98.
Castano A , Bokhari S , Maurer MS . Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis? J Am Coll Cardiol. 2015;65:311-312.
Nietlispach F , Webb JG , Ye J , et al. Pathology of transcatheter valve therapy. JACC Cardiovasc Interv. 2012;5:585-590.
Kristen AV , Schnabel PA , Winter B , et al. High prevalence of amyloid in 150 surgically removed heart valves - a comparison of histological and clinical data reveals a correlation with atheroinflammatory conditions. Cardiovasc Pathol. 2010;9:228-235.
Rapezzi C , Quarta CC , Guidalotti PL , et al. Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4(6):660-670.
Scully PR , Patel KP , Treibel TA , et al. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur Heart J. 2020;41(29):2759-2767.
Galat A , Guellich A , Bodez D , et al. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken of the egg? Eur Heart J. 2016;37:3525-3531.
Java AP , Greason KL , Dispenzieri A , et al. Aortic valve replacement in patients with amyloidosis. J Thorac Cardiovasc Surg. 2018;156(1):98-103.
Terada Y , Wanibuchi Y. Aortic valve replacement in a patient with cardiac amyloidosis. Ann Thorac Surg. 1996;62:1565-1574.
Iqbal S , Reehana S , Lawrence D. Unique type of isolated cardiac valvular amyloidosis. J Cardiothorac Surg. 2006;1(38):38.
Namaai A , Sakurai M , Sasaki O , Meguro K. Cardiac surgery in a patient with multiple myeloma combined with renal amyloidosis. Gen Thorac Cardiovasc Surg. 2010;58:341-343.
Seki T , Hattori A , Yoshida T. Hemodynamic deterioration after aortic valve replacement in a patient with mixed systemic amyloidosis. Gen Thorac Cardiovasc Surg. 2017;65:470-473.
Monticelli FC , Kunz SN , Keller T , Bleiziffer S. Cardiac amyloidosis as a potential risk factor for transapical transcatheter aortic valve implantation. J Card Surg. 2014;29(5):623-624.
Sperry BW , Jones BM , Vranian MN , Hanna M , Jaber WA . Recognizing transthyretin cardiac amyloidosis in patients with aortic stenosis: impact on prognosis. JACC Cardiovasc Imaging. 2016;9(7):904-906.
Xu B , Godoy RC , Rodriguez ER , et al. Unrecognized cardiac amyloidosis at the time of mitral valve surgery: incidence and outcomes. Cardiol. 2019;1429(4):253-258.
Coisne D , Corbi P , SOsner P. Obstructive intramural coronary amyloidosis and papillary muscle rupture. Heart. 2003;89:e8.
Frumkin D , Taube ET , Stangl K , Knebel F. Rapid progression of aortic and mitral stenosis in a patient with AA amyloidosis: a case report. Eur Heart J Case Reports. 2019;3(2).
Schwartz JG , Ghidoni JJ Unsuspected amyloidosis and cardiac arrest following mitral valve replacement. Int J Cardiol. 1985;9(4):485-487.
Engelmeier RS , O'Connell JB , Subramanian R. Cardiac amyloidosis presenting as severe mitral regurgitation. Int J Cardiol. 1983;4(3):325-327.
Nishi H , Mitsuno M , Ryomoto M , Miyamoto Y. Severe mitral regurgitation due to cardiac amyloidosis - a rare reason for ruptured chordae. Interact Cardiovasc Thorac Surg. 2008;7:1199-1200.
Cantwell RV , Aviles RJ , Bjornsson J , et al. Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris. Clin Cardiol. 2002;25(1):33-37.
Whitaker DC , Tungekar MF , Dussek JE . Angina with a normal coronary angiogram caused by amyloidosis. Heart. 2004;90(9):e54.
Massoudy P , Szabo A , Dirsch O , Wienecke H , van de Wal H , Jakob H. Amyloid of heart and lungs in a patient with low output syndrome after coronary artery bypass grafting. Herz. 2003;28(5):453-456.
Zacek P , Medilek K , Lonsky V , Laco J. Cardiac amyloidosis in the cardiosurgical operating room-a rare but fatal trap. Thorac Cardiovasc Surg. 2007;55(2):65-67.
Fitzmaurice G , Wishart V , Graham A. An unexpected mortality following cardiac surgery: A post-mortem diagnosis of cardiac amyloidosis. Gen Thorac Cardiovasc Surg. 2013;61(7):417-421.
Massias S , Vyssoulis G , Rizos I , Barbetseas I , Stefanadis C. Progressive heart failure in a patient after coronary artery bypass grafting. Hell J Cardiol. 2006;47:114-11.
Smith A , Edlin J , Hinds C , Ambekar S. Coronary revascularization in cardiac amyloidosis. J Card Surg. 2020;35(11):3248-3250.